Literature DB >> 17333055

[The heart in cases of viral, bacterial and parasitic infections].

B Maisch1, P Alter, K Karatolius, V Ruppert, S Pankuweit.   

Abstract

The heart can be the primary target for a viral, bacterial or parasitic infection (primary myocarditis/inflammatory cardiomyopathy). It can also participate in the "collateral damage" due to toxins, chemo- and cytokines, autoreactive antibodies or the native and acquired immune response through T- and B-cells, monocytes and macrophages (secondary myocarditis/inflammatory cardiomyopathy), when it is not the dominant organ of the disease. Infective agents show remarkable organ specificity: viral infections, toxic and autoreactive processes affect primarily the myocardium and the pericardium, whereas bacterial infections prefer endothelial surfaces and cause endocarditis and, less frequently, pericarditis. They are even discussed as part of the inflammatory process involved in coronary artery disease. Infective agents and their adequate diagnosis and treatment are discussed for these clinical entities according to current guidelines and clinical pathways.

Entities:  

Mesh:

Year:  2007        PMID: 17333055     DOI: 10.1007/s00108-006-1775-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Inflammatory dilated cardiomyopathy (DCMI).

Authors:  Bernhard Maisch; Anette Richter; Andrea Sandmöller; Irene Portig; Sabine Pankuweit
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

2.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  [Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis].

Authors:  B Maisch; K Karatolios; S Pankuweit
Journal:  Dtsch Med Wochenschr       Date:  2006-09-29       Impact factor: 0.628

4.  Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment.

Authors:  José Zamorano; Javier Sanz; Carlos Almería; Jose-Luis Rodrigo; Miriam Samedi; Dioniosio Herrera; Adalia Aubele; Luis Mataix; Viviana Serra; Raúl Moreno; Luis Sánchez-Harguindei
Journal:  J Heart Valve Dis       Date:  2003-03

Review 5.  [Acute myocarditis and cardiomyopathy in Lyme borreliosis].

Authors:  N Scheffold; C Sucker; J Bergler-Klein; N Kaag; J Cyran
Journal:  Z Kardiol       Date:  2000-11

6.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

7.  Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study.

Authors:  C F N Koegelenberg; A F Doubell; H Orth; H Reuter
Journal:  QJM       Date:  2003-03

8.  Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.

Authors:  Daniela Massi; Alessandro Franchi; Sheyda Ketabchi; Milena Paglierani; Nicola Pimpinelli; Marco Santucci
Journal:  Hum Pathol       Date:  2003-01       Impact factor: 3.466

9.  Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves.

Authors:  Peter Alter; Jutta Hoeschen; Michael Ritter; Bernhard Maisch
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778

Review 10.  Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects.

Authors:  Fiorella Calabrese; Gaetano Thiene
Journal:  Cardiovasc Res       Date:  2003-10-15       Impact factor: 10.787

View more
  6 in total

1.  [Inflammatory diseases of the heart].

Authors:  B E Strauer; H P Schultheiss
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

2.  Diagnostic approaches for pericardial effusions : Beyond mere cytopathology.

Authors:  A G Rigopoulos; M Ali; S Sakellaropoulos; M Matiakis; M Teren; M Mammadov; B Ahmadzada; M Noutsias
Journal:  Herz       Date:  2017-12-15       Impact factor: 1.443

Review 3.  [Myocarditis and sudden cardiac death in athletes. Diagnosis, treatment, and prevention].

Authors:  Matthias Frick; Otmar Pachinger; Gerhard Pölzl
Journal:  Herz       Date:  2009-06       Impact factor: 1.443

Review 4.  [New possibilities of diagnostics and therapy of pericarditis].

Authors:  B Maisch; K Karatolios
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

5.  Septic cardiomyopathy: evidence for a reduced force-generating capacity of human atrial myocardium in acute infective endocarditis.

Authors:  Katja Buschmann; Ryan Chaban; Anna Lena Emrich; Marwan Youssef; Angela Kornberger; Andres Beiras-Fernandez; Christian Friedrich Vahl
Journal:  Innov Surg Sci       Date:  2017-04-13

Review 6.  Non-invasive imaging in the diagnosis of acute viral myocarditis.

Authors:  Michael Jeserich; Stavros Konstantinides; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2009-09-11       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.